The pharma group is forecasting a year of growth.
A modest recovery at the end of 2021 was dented by the omicron outbreak.
The NZ research firm runs trials for international pharmaceutical companies.
Former workers are critical of the organisation's chief executive.
To join your company account for BusinessDesk and enjoy full access, enter your email and we’ll send you details